Group One Trading’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-97
Closed -$345 7678
2026
Q1
$307 Hold
97
﹤0.01% 7367
2025
Q4
$469 Buy
+97
New +$405 ﹤0.01% 7815
2024
Q2
Sell
-1,523
Closed -$4K 6806
2024
Q1
$4.04K Buy
1,523
+1,193
+362% +$3.3K ﹤0.01% 6272
2023
Q4
$1.02K Buy
+330
New +$783 ﹤0.01% 6984
2020
Q4
Sell
-200
Closed -$4.49K 6545
2020
Q3
$4K Hold
200
﹤0.01% 5673
2020
Q2
$4K Buy
+200
New +$3.04K ﹤0.01% 5410
2018
Q3
Sell
-5,995
Closed -$172K 5229
2018
Q2
$170K Buy
+5,995
New +$179K ﹤0.01% 3180

Other funds holding CLLS

Group One Trading's CLLS Position: Q2 2026 in Review

Group One Trading sold out of Cellectis (CLLS) in Q2 2026, closing a stake of 97 shares — an estimated $345 sold.

Group One Trading first reported a position in CLLS in Q2 2018 and held it in 7 quarters. The position peaked at $170K in Q2 2018. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Group One Trading reported no remaining Cellectis position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 97 Cellectis shares in Q2 2026, an estimated $345.
  • Group One Trading first reported a position in Cellectis in Q2 2018 and held it in 7 quarters.
  • Group One Trading's Cellectis position peaked at $170K in Q2 2018.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.